Kind of. firstly although I haven’t looked up the other trial they reference but it’s quite possible this includes patients that would have been screened out of the current trial as “placebo responders”. Secondly, the ftt graph contains placebo (standard of care) participants as well as those being treated by the drug. So the difference could be bigger than indicated by the graph.
For me if I had a VLU and there was a choice between it taking six months to heal with standard of care or possibly healing within 12 weeks I know what I would prefer...?
Just random thoughts
- Forums
- ASX - By Stock
- DLM
- Ann: Investor Presentation
Ann: Investor Presentation, page-4
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable